Chemours Co Stock EBITDA
| CC Stock | USD 20.80 1.55 8.05% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 197 M | 187.2 M |
Chemours | EBITDA |
Chemours Co Company EBITDA Analysis
Chemours' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Chemours EBITDA | 197 M |
Most of Chemours' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chemours EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as EBITDA. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
Chemours EBITDA Historical Pattern
Today, most investors in Chemours Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemours' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chemours ebitda as a starting point in their analysis.
Chemours EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Chemours Ebitda
Ebitda |
|
According to the company disclosure, Chemours Co reported earnings before interest,tax, depreciation and amortization of 197 M. This is 75.23% lower than that of the Chemicals sector and 76.9% lower than that of the Materials industry. The ebitda for all United States stocks is 94.95% higher than that of the company.
Chemours EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in ebitda category among its peers.
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 3.0B | 4.1B | 4.8B | 4.7B | 3.6B | |
| Enterprise Value | 7.8B | 6.4B | 7.3B | 7.5B | 7.8B | 5.3B |
Chemours ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chemours' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chemours' managers, analysts, and investors.Environmental | Governance | Social |
Chemours Institutional Holders
Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.| Shares | Lsv Asset Management | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.7 M | Appian Way Asset Management | 2024-09-30 | 1.7 M | Luminus Management, Llc | 2024-09-30 | 1.6 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.6 M | Massachusetts Financial Services Company | 2024-09-30 | 1.5 M | American Century Companies Inc | 2024-09-30 | 1.5 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.5 M | Vision One Management Partners Lp | 2024-09-30 | 1.4 M | Fmr Inc | 2024-09-30 | 18.1 M | Blackrock Inc | 2024-06-30 | 16.3 M |
Chemours Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0397 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 6.8 B | |||
| Shares Outstanding | 149.41 M | |||
| Shares Owned By Insiders | 0.72 % | |||
| Shares Owned By Institutions | 82.85 % | |||
| Number Of Shares Shorted | 7.7 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 4.73 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 6.03 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 197 M | |||
| Net Income | (238 M) | |||
| Cash And Equivalents | 1.1 B | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.3 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 4.40 X | |||
| Cash Flow From Operations | 556 M | |||
| Short Ratio | 5.37 X | |||
| Earnings Per Share | 0.50 X | |||
| Price To Earnings To Growth | 1.67 X | |||
| Target Price | 24.9 | |||
| Number Of Employees | 6.2 K | |||
| Beta | 1.75 | |||
| Market Capitalization | 3.11 B | |||
| Total Asset | 8.25 B | |||
| Retained Earnings | 1.78 B | |||
| Working Capital | 1.35 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 3.59 % | |||
| Net Asset | 8.25 B | |||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.